Skin experts unite to tackle melasma confusion
NCT ID NCT07296549
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study brings together 15 dermatologists to agree on the best ways to diagnose and treat melasma, a skin condition that causes dark patches on the face. Using a survey method called Delphi, experts will share their knowledge anonymously over several rounds. The goal is to create clear, evidence-based guidelines that help doctors worldwide provide more consistent care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could produce clear, expert-backed guidelines to help doctors treat melasma more consistently and effectively worldwide.
- What could go wrong
- This is a small, early-stage consensus study with only 15 experts, not a clinical trial testing a treatment. The guidelines may not reflect all patient experiences or lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Venus Research Center
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple pill make melasma creams work better?
- Can a two-acid cream fade stubborn melasma?
- Microneedling boosts melasma treatments: could metformin or tranexamic acid outperform standard creams?
- Can sunscreen do more than protect? study tests if it fades dark spots
- New cream trio aims to outshine standard melasma treatment
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea